Cochlear Limited (ASX:COH – Get Free Report) insider Karen Penrose acquired 100 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The shares were acquired at an average cost of A$201.22 per share, with a total value of A$20,122.00.
Cochlear Price Performance
The company has a debt-to-equity ratio of 13.24, a quick ratio of 1.93 and a current ratio of 2.30. The stock has a market cap of $19.88 billion, a P/E ratio of 55.90, a PEG ratio of 3.87 and a beta of 0.47.
Cochlear Announces Dividend
The business also recently disclosed a Interim dividend, which will be paid on Sunday, April 12th. Stockholders of record on Sunday, April 12th will be issued a $2.15 dividend. This represents a dividend yield of 107.0%. The ex-dividend date is Wednesday, March 18th. Cochlear’s dividend payout ratio is currently 77.35%.
About Cochlear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
See Also
- Five stocks we like better than Cochlear
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Gold $5,000: The 2026 Gold & Silver Summit is LIVE March 4
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
